Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Scrip Asks… What Does 2019 Hold For Biopharma? Part 2: Business Trends

Jan 08 2019

• By Eleanor Malone

2019 2018 Perspectives

Related Content

Mysterious Amazon/Berkshire/JPMorgan Partnership Could Disrupt Health Care, Pharma

Jan 31 2018

Lift-Off For Lilly In Cancer Genetics With Loxo Buy

Jan 07 2019

Bristol Values Celgene's Hematology, Immunology Portfolio At $74bn, But Does It Price In Risk?

Jan 04 2019

Get Ready For The Return Of The Mega-Merger, Leerink Says

Mar 16 2018

Deal Watch: Amazon Moves Into Rx Services With Acquisition Of PillPack

Jul 02 2018

Scrip Asks... What Will 2019 Hold For Biopharma? Part 1: Therapeutic Advances

Dec 24 2018

‘Going Digital’ Is Changing Pharma’s Processes, People And Culture

Aug 28 2018

Related Companies

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Eli Lilly and Company

Loxo Oncology at Lilly

Sanofi

Sanofi

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

GSK plc

Tesaro, Inc.

Bayer AG

Boehringer Ingelheim GmbH

Roche Holding AG

Roche Holding AG

Boehringer Ingelheim GmbH

Additional Topics

Business Strategies Financing M & A Deals Digital Health Artificial Intelligence Clinical Trials Manufacturing Strategy Commercial Scrip Asks BioPharmaceutical

More from Scrip Asks

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window